Resveratrol suppresses breast cancer cell invasion by inactivating a RhoA/YAP signaling axis

Yu Na Kim, So Ra Choe, Kyung Hwa Cho, Do Yeun Cho, Jaeku Kang, Chang Gyo Park, Hoi Young Lee

Experimental & Molecular Medicine · 2017 · 66 citations · 45 references

DOIFull text

Open access

Concepts

Abstract

Hippo/YAP signaling is implicated in tumorigenesis and progression of various cancers. By inhibiting a plethora signaling cascades, resveratrol has strong anti-tumorigenic and anti-metastatic activity. In the present study, we demonstrate that resveratrol decreases the expression of YAP target genes. In addition, our data showed that resveratrol attenuates breast cancer cell invasion through the activation of Lats1 and consequent inactivation of YAP. Strikingly, we also demonstrate that resveratrol inactivates RhoA, leading to the activation of Lats1 and induction of YAP phosphorylation. Further, resveratrol in combination with other agents that inactivate RhoA or YAP showed more marked suppression of breast cancer cell invasion compared with single treatment. Collectively, these findings indicate the beneficial effects of resveratrol on breast cancer patients by suppressing the RhoA/Lats1/YAP signaling axis and subsequently inhibiting breast cancer cell invasion. Resveratrol, a compound found in red wine, inhibits the growth of breast cancer cells by inactivating a cell proliferation pathway. The Yes-associated protein (YAP) and related proteins promote cancer's spread by shutting down the mechanism by which normal cells stop growing when they come into contact with each other. Hoi Young Lee and colleagues from Konyang University in Daejeon, South Korea, treated breast cancer cells with resveratrol, a known tumor-blocking agent found in grape skins and other foods, and observed a reduction in the expression levels of genes targeted by YAP. Resveratrol also altered the activity of various regulators of YAP expression itself. Treatment with an inhibitor of one of these regulators combined with resveratrol led to stronger suppression of cancer cell invasion, suggesting a new therapeutic strategy for breast cancer patients.

References

45